AI @ HLTH: Harnessing AI for Diabetic Retinopathy
In this episode, host Sandy Vance chats with Optomed Managing Director David Frasch about how AI can augment physicians' abilities and daily responsibilities in this space. Optomed is a handheld fundus camera manufacturer based in Finland and has been in operation for the last 20 years.
Listen as David sheds light on how Optomed cameras harness the power of AI to enhance the diagnosis and management of diabetic retinopathy. They explore the development of cutting-edge algorithms for medical diagnostics, the challenges of creating clinical algorithms without standardization, and the broad applications of AI across the healthcare sector. Stay tuned for a fascinating discussion on the transformative impact of AI in healthcare!
A Little About David:
With a decade of experience in medical sales within ophthalmology, David has recently excelled in building high-performance sales teams at BioTissue. As a director there, he successfully transformed the team's performance from worst to first, a process that was both challenging and rewarding. In his new role at Optomed, David aims to replicate this success by focusing on team development and growth. He is committed to growing the team in a controlled manner and laying a strong foundation for building a powerful and resilient organization.
In this episode, they talk about:
- How Optomed leverages AI to improve diagnosis and treatment of diabetic retinopathy
- Developing advanced algorithms for medical diagnostics
- Challenges in creating optimal clinical algorithms without standardization
- Applications of AI across various sectors in the healthcare industry
- Addressing ethical and privacy concerns in AI-driven healthcare solutions
- Emerging trends in the application of AI in medicine and healthcare
- The strategic partnership between AI Health and Optomed
- Future collaborative opportunities between AI Health and physicians